Search Results - antigen-binding+fragment

2 Results

Sort By:

Chimeric Antigen Receptors to CD276 for Treating Cancer

Abstract: Chimeric antigen receptors (CARs) are hybrid proteins consisting of an antibody binding fragment fused to protein signaling domains that cause T-cells which express the CAR to become cytotoxic. Once activated, these cytotoxic T-cells can selectively eliminate the cells which they recognize via the antibody binding fragment of the CAR. By...

Published: 6/24/2025 | Updated: 8/2/2023 | Inventor(s): Crystal Mackall, Yongzhi Cui

Keywords(s): adoptive cell therapy, ANTIBODY, antigen-binding fragment, CAR, Neuroblastoma

Category(s): Application > Therapeutics, Collaboration Sought > Licensing, TherapeuticArea > Oncology

Single Domain Antibodies (Nanobodies) Targeting SARS-CoV-2 for treating COVID-19

Summary: The NCI seeks licensing and/or co-development research collaborations for SARS-CoV-2 targeting nanobodies. Description of Technology: The COVID-19 pandemic is a worldwide public health crisis with over 100 million confirmed cases and 2.4 million deaths as of February 2021. COVID-19 is caused by a novel coronavirus called SARS-CoV-2. SARS-COV-2...

Published: 4/24/2026 | Updated: 8/2/2023 | Inventor(s): Mitchell Ho, Jessica Hong

Keywords(s): ANTIBODY, antigen-binding fragment, CORONAVIRUS, COVID-19, HO, NANOBODY, respiratory INFECTION, S Protein, SARS-CoV-2, spike protein

Category(s): TherapeuticArea > Infectious Disease, Collaboration Sought > Licensing, Collaboration Sought > Collaboration, Application > Therapeutics